Patents Assigned to iX Biopharma Ltd.
  • Patent number: 11975097
    Abstract: There is provided a fast dissolving solid dosage form adapted for the release of a biologically active material in the oral cavity wherein the dosage form comprises at least one biologically active material, and at least one matrix forming agent, wherein the dosage form substantially dissolves in the oral cavity. A method of producing the same and a kit comprising the same are also provided.
    Type: Grant
    Filed: April 9, 2020
    Date of Patent: May 7, 2024
    Assignee: iX Biopharma Ltd.
    Inventors: Chin Beng Stephen Lim, Vivian Bruce Sunderland, Yip Hang Eddy Lee
  • Patent number: 10857097
    Abstract: There is provided a solid dosage form adapted for the release of a biologically active material in the oral cavity wherein the dosage form includes at least one biologically active material, and at least one matrix forming agent, wherein the dosage form substantially dissolves in the oral cavity. A method of producing the same and a kit including the same are also provided.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: December 8, 2020
    Assignee: iX Biopharma Ltd.
    Inventors: Chin Beng Stephen Lim, Vivian Bruce Sunderland, Yip Hang Eddy Lee
  • Patent number: 10744086
    Abstract: There is provided a fast dissolving solid dosage form adapted for the release of a biologically active material in the oral cavity wherein the dosage form comprises at least one biologically active material, and at least one matrix forming agent, wherein the dosage form substantially dissolves in the oral cavity. A method of producing the same and a kit comprising the same are also provided.
    Type: Grant
    Filed: October 26, 2010
    Date of Patent: August 18, 2020
    Assignee: iX Biopharma Ltd.
    Inventors: Chin Beng Stephen Lim, Vivian Bruce Sunderland, Yip Hang Eddy Lee